Nashville, TN
On April 15th Wilson Sonsini partner Andrea Linna will present on the panel “Representing the Founders, Investors, and Innovators of Healthcare AI: Venture Capital and Emerging Companies.” The session will explore the central role venture capital plays in bringing healthcare AI to market and the complex legal landscape that founders and investors must navigate.
Key topics to be addressed during the panel include:
Wednesday, April 15, 2026 | 8:00 - 9:15 AM | Representing the Founders, Investors, and Inventors of Health Care AI: Venture Capital and Emerging Companies
Panelists
The health law industry continues to evolve, and as such, industry professionals must stay up to date on the legal and business issues to consider when structuring deals and transactions for their clients and institutions. In-house and outside counsel, compliance professionals, consultants, and private equity professionals and venture capitalists will gain key insights regarding business and legal issues in mergers, acquisitions, joint ventures, and other health care transactions. Attendees of this conference will develop knowledge surrounding current developments, strategies, and deal forecasts and learn critical business considerations that must be addressed before, during, and after a transaction.
Madelaine Holden
mholden@wsgr.com
Andrea Linna is a partner at Wilson Sonsini Goodrich & Rosati, where she is a member of the firm’s digital health industry group and its healthcare practice. With more than a decade dedicated to healthcare law, Andrea exclusively represents digital health and healthcare IT clients, from emerging companies to established industry players, investors, and healthcare systems. Andrea guides her clients through the patchwork of federal and state laws that apply to digital health companies, addressing issues such as corporate practice of medicine, Stark Law compliance, Anti-Kickback Statute considerations, fee splitting, billing Medicare and Medicaid, contracting with commercial payors, value-based care arrangements, artificial intelligence, remote patient monitoring, online prescribing, scope of practice, and licensing requirements.